In estrogen-dependent cancers such as breast cancer, investigators reported that BIG3, a key molecular regulator in the ER signaling pathway, inhibits the nuclear transportation of the PHB2/REA transcription complex, abolishing the inhibitory effect of the PHB2/REA complex on ERα transcriptional activity73, 74. Here, PHB2 is linked to breast carcinoma.